Recombinant SARS-CoV-2 Spike S1 antibody (AA 1-674)
Quick Overview for Recombinant SARS-CoV-2 Spike S1 antibody (AA 1-674) (ABIN7384985)
Target
See all SARS-CoV-2 Spike S1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-674
-
Specificity
- Recombinant antibody sequence derived from SARS-CoV-2 positive human lymphocytes
-
Characteristics
- Recommended usage: dilute with PBS/1 % BSA to 1-10 μg/mL and freeze at -20 °C in use size aliquots. Do not store diluted material for more than 24 hours at 2-8 °C.
-
Purification
- Affinity Purified Recombinant Monoclonal Antibody
-
Purity
- >90 % by SDS-PAGE
-
Immunogen
- SARS-CoV-2 S1 domain (1-674 aa)
-
Isotype
- IgM, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.015M Potassium Phosphate, pH 7.2 with 0.85 % Sodium Chloride,0.05 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C. Avoid repeated freezing and thawing.
-
-
- SARS-CoV-2 Spike S1
Target
-